{"schema_version":"1","generated_at":"2026-11-17T01:20:47.445Z","data_as_of":null,"url":"https://www.findmykol.com/kol/prashant-vempati","json_url":"https://www.findmykol.com/kol/prashant-vempati/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"prashant-vempati","name":"Prashant Vempati","credential":"MD, MS","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1487017935","orcid":"0000-0003-0398-8088","openalex":"A5003868716"},"summary":"Prashant Vempati is an Oncology physician. OpenAlex indexes 58 publications with 1,352 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":58,"cited_by_count":1352,"h_index":14,"latest_activity_year":2026,"emerging":true,"source":"works"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"Novartis","program_year":2025,"amount_usd":22957.57,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1487017935"},{"payer":"Telix Pharmaceuticals","program_year":2025,"amount_usd":112.12,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1487017935"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":20.49,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1487017935"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1487017935","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Sensory organs","share_pct":59.5,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":59.5,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":20}]},{"area":"Metabolism & gastrointestinal","share_pct":40.5,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":40.5,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"RTAD-04 LOW-DOSE RADIATION INDUCES HER2 UPREGULATION AND ENHANCES EFFICACY OF TRASTUZUMAB DERUXTECAN IN BREAST CANCER BRAIN METASTASES","year":2026,"journal":"Neuro-Oncology Advances","source_url":"https://doi.org/10.1093/noajnl/vdag161.081","status":"verified"},{"title":"Novel Tool to Predict Primary Tumor Location in the Setting of Metastatic Cancer With Unknown Primary","year":2026,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op-26-00212","status":"verified"},{"title":"High-grade glioma with dural progression: A single-center case series and review of literature","year":2026,"journal":"Radiology Case Reports","source_url":"https://doi.org/10.1016/j.radcr.2026.04.040","status":"verified"},{"title":"Artificial intelligence applications in neuro-oncology","year":2026,"journal":"Elsevier eBooks","source_url":"https://doi.org/10.1016/b978-0-443-27356-8.00047-4","status":"verified"},{"title":"Navigating the Complexities of Skull Base Paragangliomas: Case Report and Overview with Emphasis on Multi-Disciplinary Approach to Diagnosis and Management","year":2026,"journal":"Journal of Neurological Surgery Part B Skull Base","source_url":"https://doi.org/10.1055/s-0046-1819090","status":"verified"}],"source":"works"},"contact":{"address_1":"1000 10TH AVE","address_2":"SUITE 3A-15","city":"New York","state":"NY","zip":"100191147","phone":"212-523-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1487017935","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":8,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-05-04","provider_certified":"2021-05-04","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}